SecBot SecBot
144 ·Filed Nov 13, 2026

RCKT

ROCKET PHARMACEUTICALS, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3d 10h ago SEC0001959173-26-008008
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The sale is a routine tax-withholding transaction tied to equity vesting. No material insider sentiment signal; monitor for any larger unplanned sales in future Form 4 filings.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$2.30
T+0 close · Nov 13, 2026 · via day close
Latest settled
−6.09%
T+1 · $2.16
Vs SPY
−4.18%
α at T+1
Next horizon
T+5
in 3d
  1. T+0 · Nov 13 $2.30entry
  2. T+1 · 20h ago −6.09%α −4.18% · $2.16
  3. T+5 · in 3d Pending
  4. T+20 · in 27d Pending
  5. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Officer Martin Wilson filed Form 144 notice to sell 4,087 shares of Rocket Pharmaceuticals, valued at approximately $9,197, with the sale intended to cover a tax obligation from a vested equity award distribution. The amount is trivial relative to the company's $272M market cap and Wilson's recent trading history, making this a routine administrative filing.

Key Facts

  • Wilson Martin, an officer of Rocket Pharmaceuticals, filed Form 144 on 2026-11-13 to sell 4,087 shares of common stock.
  • The proposed sale value is $9,196.98, based on an estimated price of $2.25 per share.
  • The filing states the sale is to cover a tax obligation from the settlement of a vested equity award distribution.
  • Wilson Martin has sold 133,877 shares in four transactions since August 2026, totaling approximately $398,238.
  • The company's market cap is $272M, making this proposed sale about 0.003% of market cap.

Financial Impact

Proposed sale of 4,087 shares worth ~$9,197, less than 0.004% of market cap.

dilution

Risk Factors

  • Form 144 is an intent to sell; the actual sale may not occur or may differ in size.
  • The officer has sold over 130K shares since August 2026, which could indicate ongoing portfolio diversification rather than a negative view.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
60% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-008008
Document: 0001959173-26-008008-index.html0001959173-26-008008
Document: 0001959173-26-008008.txt0001959173-26-008008

Track record

21 reports on RCKT

Performance horizon

5 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +42.18% at T+20 after the Jun 12, 2026 report. 6 of 6 went positive at some point.

Filters
  1. Nov 13, 20263d ago 144 Neutral 2/10 Entry $2.45 Now $2.16 −11.84% settles Dec 15
  2. Nov 13, 20263d ago 144 Neutral 2/10 Viewing Entry $2.30 Now $2.16 −6.09% settles Dec 14
  3. Nov 12, 20264d ago Insider Cluster Neutral 3/10 Entry $2.30 Now $2.16 −6.09% settles Dec 14
  4. Nov 12, 20264d ago 8-K Neutral 5/10 Entry $2.30 Now $2.16 −6.09% settles Dec 14
  5. Nov 9, 20267d ago 144 Neutral 2/10 Entry $2.53 Now $2.16 −14.62% settles Dec 8
  6. Nov 9, 20267d ago 144 Neutral 2/10 Entry $2.53 Now $2.16 −14.62% settles Dec 8
  7. Nov 5, 202611d ago 144 Neutral 2/10 Entry $2.44 Now $2.16 −11.29% settles Dec 4
  8. Oct 30, 202617d ago SC 13G/A Neutral 2/10 Entry $2.44 Now $2.16 −11.48% settles Nov 30
  9. Oct 6, 20265w ago 8-K Bullish 7/10 Entry $2.54 to $2.57 Now $2.16 −14.79% ▲ +1.38% +2.62% vs SPY
  10. Sep 15, 20268w ago 8-K Bullish 7/10 Entry $3.41 to $2.30 Now $2.16 −36.66% ▼ −32.55% −35.27% vs SPY
Showing 10 of 21

US Market Status

Market Closed · Opens in 6h 41m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026